Overview
- Acting CDC director Jim O’Neill on Monday adopted new ACIP guidance from the recently reconstituted panel installed after the prior committee was dismissed in June.
- COVID-19 vaccination is now framed as an individual decision made with a clinician, with O’Neill emphasizing a return to informed consent as some medical groups object to the framing.
- Reporting indicates the FDA has limited marketing indications for updated COVID-19 shots to adults 65 and older and people with qualifying medical risk factors.
- Most insurers are expected to keep paying for COVID-19 vaccines through at least 2026, and the federal Vaccines for Children program can continue supplying pediatric doses.
- For young children, first doses of measles-mumps-rubella and varicella are now recommended as separate shots, with the combined MMRV remaining an option for the second dose due to a small febrile-seizure risk with the early combined dose.